Overview
Neonatal alloimmune neutropenia (NAN), also called neonatal alloimmune neutropenia or alloimmune neonatal neutropenia, is a blood condition that affects newborn babies. It happens when a mother's immune system makes antibodies against proteins (called antigens) found on the surface of her baby's white blood cells, specifically a type called neutrophils. These neutrophils are important for fighting bacterial infections. During pregnancy, the mother's antibodies cross the placenta and attack the baby's neutrophils, causing a dangerously low neutrophil count (neutropenia) in the newborn. The condition is similar in concept to hemolytic disease of the newborn, but instead of red blood cells being affected, it is the white blood cells. Babies with NAN are at increased risk of bacterial infections, which can range from mild skin infections to serious life-threatening conditions like sepsis or meningitis. Some babies may have no symptoms at all and are only discovered through routine blood tests, while others may develop fever, skin infections, or umbilical cord infections shortly after birth. The good news is that NAN is usually a self-limiting condition. As the mother's antibodies are gradually cleared from the baby's bloodstream over weeks to months, the neutrophil count typically returns to normal. Treatment depends on severity and may include antibiotics for infections and, in more serious cases, granulocyte colony-stimulating factor (G-CSF) to boost neutrophil production. Intravenous immunoglobulin (IVIG) may also be used. Most babies recover fully within the first few months of life.
Key symptoms:
Low white blood cell count (neutropenia) at birthSkin infections or rashesUmbilical cord infection (omphalitis)Fever in the newborn periodDelayed separation of the umbilical cordBacterial bloodstream infection (sepsis)Pneumonia or lung infectionsUrinary tract infectionsSoft tissue abscessesIrritability or poor feedingMeningitis in severe cases
Clinical phenotype terms (12)— hover any for plain English
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Neonatal alloimmune neutropenia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Neonatal alloimmune neutropenia at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Neonatal alloimmune neutropenia.
Community
No community posts yet. Be the first to share your experience with Neonatal alloimmune neutropenia.
Start the conversation →Latest news about Neonatal alloimmune neutropenia
No recent news articles for Neonatal alloimmune neutropenia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How low is my baby's neutrophil count, and how often will it be checked?,Does my baby need treatment right now, or can we monitor and wait?,What signs of infection should I watch for at home, and when should I go to the emergency room?,How long will it take for my baby's neutrophil count to return to normal?,If I have another baby, what is the chance this will happen again, and can anything be done to prevent it?,Should I avoid breastfeeding, or is it safe for my baby?,Are there any vaccines or routine procedures we should delay while my baby's neutrophil count is low?
Common questions about Neonatal alloimmune neutropenia
What is Neonatal alloimmune neutropenia?
Neonatal alloimmune neutropenia (NAN), also called neonatal alloimmune neutropenia or alloimmune neonatal neutropenia, is a blood condition that affects newborn babies. It happens when a mother's immune system makes antibodies against proteins (called antigens) found on the surface of her baby's white blood cells, specifically a type called neutrophils. These neutrophils are important for fighting bacterial infections. During pregnancy, the mother's antibodies cross the placenta and attack the baby's neutrophils, causing a dangerously low neutrophil count (neutropenia) in the newborn. The con
How is Neonatal alloimmune neutropenia inherited?
Neonatal alloimmune neutropenia follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Neonatal alloimmune neutropenia typically begin?
Typical onset of Neonatal alloimmune neutropenia is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Neonatal alloimmune neutropenia?
2 specialists and care centers treating Neonatal alloimmune neutropenia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.